1. Home
  2. TMDE vs NRSN Comparison

TMDE vs NRSN Comparison

Compare TMDE & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$2.04

Market Cap

21.7M

Sector

Energy

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.79

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
NRSN
Founded
2016
2017
Country
Malaysia
Israel
Employees
N/A
15
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
24.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TMDE
NRSN
Price
$2.04
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.5M
187.1K
Earning Date
05-13-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.63
52 Week High
$4.77
$2.60

Technical Indicators

Market Signals
Indicator
TMDE
NRSN
Relative Strength Index (RSI) 57.94 46.20
Support Level $0.64 $0.66
Resistance Level $2.75 $1.30
Average True Range (ATR) 0.25 0.07
MACD 0.02 0.01
Stochastic Oscillator 73.38 64.35

Price Performance

Historical Comparison
TMDE
NRSN

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: